Stay updated on IBI310 and Siltilimab in NPC Clinical Trial
Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, and the prior revision v3.3.3 was removed; these are administrative version-tracking changes with no impact on study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page history.SummaryDifference0.2%

- Check53 days agoChange DetectedFooter shows the site revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding/operating status banner at the top of the page was removed. This change affects only the header/banner and does not alter the study data or how the page functions.SummaryDifference0.8%

- Check82 days agoChange DetectedVersions 2–4 show updates to the study's Recruitment Status, reflecting changes in enrollment activity over time and the current status of participant recruitment.SummaryDifference0.1%

- Check103 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference13%

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.